Boehringer Ingelheim fined in Romania for lung-drug dominance abuse
MLex Summary: Pharmaceutical company Boehringer Ingelheim has been fined more than 128 million lei (around $26.4 million) in Romania, for abusing its dominant position on the market for drugs used to...To view the full article, register now.
Already a subscriber? Click here to view full article